FDA Approves Mylan’s Interchangeable Biosimilar Insulin Product
AstraZeneca’s COVID-19 Vaccine 82% Effective Against Variants
AbbVie, Calico Extend Partnership for Age-Related Disease Therapies
FDA Approves Merck’s Keytruda for Triple-Negative Breast Cancer
FDA Approves Merck’s Keytruda Treatment for Endometrial Carcinoma
Bristol Myers Squibb Pulls Immunotherapy Opdivo from US Market
Pharmaceutical Supply Chain Needs Reform for Transparency, Access
Pfizer, Arvinas to Develop Protein Degrader for Breast Cancer
FDA Grants Breakthrough Therapy for Roche’s MDS Treatment
High-Dose Buprenorphine Helped Untreated Opioid Use Disorder
Lilly Enters Collaboration for Phase 3 Trial of Alzheimer’s Drug
FDA Approves Sanofi’s All-Oral Treatment for Sleeping Sickness
Pfizer Completes Trial Enrollment for Lyme Disease Vaccine
BioNTech to Acquire Kite’s TCR Platform for Cell Therapy Pipeline
Eli Lilly Enters Pharma Acquisition Deal for Diabetes Treatment
J&J COVID-19 Vaccine Elicits Antibody Responses Against Variants
Biogen, InnoCare Pharma Partner for Multiple Sclerosis Treatment
FDA Authorizes Ortho Clinical’s COVID-19 Antibody Test
St. Jude Medical to Pay $27M to Resolve Healthcare Fraud Allegations
Study Finds Major Medicare Overspending Generic Prescription Drugs
Moderna Doses First Patient in Study of Flu mRNA Vaccine Candidate
Medicare Prescription Drug Prices Doubled Since 2005
Gavi Signs Agreement for Sinopharm, Sinovac COVID-19 Vaccine Doses
FDA Updates J&J COVID-19 Vaccine Label to Include Rare Disorder
FDA Seeks Investigation Over Approval of Alzheimer’s Drug, Aduhelm
Pfizer, AbbVie, Biogen Launch Resource for Genetic Variants
Thermo Fisher, UC Davis Launch Center of Excellence for Metabolomics
FDA: Aduhelm Only to Be Given to Early-Stage Alzheimer’s Patients
Improving Health Equity Across the Pharmaceutical Industry
FDA Issues Complete Response Letter for Type 1 Diabetes Antibody
Merck Gains FDA Approval for Expanded Indication of Keytruda
J&J COVID-19 Vaccine Neutralizes Activity Against Delta Variant
GSK, Alector to Develop Antibodies for Neurodegenerative Diseases
AstraZeneca’s Antibody Favorable in RSV in Phase 2/3 Trial
FDA Approves Key Component for Common Childhood Cancer Treatment
Pfizer Halts Distribution of Smoking Cessation Drug, Chantix
Gilead Submits New Drug Application to FDA for HIV Treatment
DTC Pharmaceutical Marketing Linked $324B in Medicare Drug Spending
Higher Dose of Ozempic Further Advances Diabetes Care Management